JP2019017287A - Preventive/ameliorating agent for muscular fatigue or the like, containing hydrogen, and food and drink composition - Google Patents

Preventive/ameliorating agent for muscular fatigue or the like, containing hydrogen, and food and drink composition Download PDF

Info

Publication number
JP2019017287A
JP2019017287A JP2017138035A JP2017138035A JP2019017287A JP 2019017287 A JP2019017287 A JP 2019017287A JP 2017138035 A JP2017138035 A JP 2017138035A JP 2017138035 A JP2017138035 A JP 2017138035A JP 2019017287 A JP2019017287 A JP 2019017287A
Authority
JP
Japan
Prior art keywords
hydrogen
agent
beverage
preventive
fatigue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2017138035A
Other languages
Japanese (ja)
Inventor
吉武 馬場
Yoshitake Baba
吉武 馬場
光 杉浦
Hikari Sugiura
光 杉浦
貴之 越智
Takayuki Ochi
貴之 越智
瀧原 孝宣
Takanobu Takihara
孝宣 瀧原
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ito En Ltd
Original Assignee
Ito En Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ito En Ltd filed Critical Ito En Ltd
Priority to JP2017138035A priority Critical patent/JP2019017287A/en
Publication of JP2019017287A publication Critical patent/JP2019017287A/en
Withdrawn legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Non-Alcoholic Beverages (AREA)

Abstract

To provide a novel preventive/ameliorating agent or the like for muscular fatigue.SOLUTION: There is provided a preventive/ameliorating agent or the like for muscular fatigue, containing hydrogen as an active ingredient.SELECTED DRAWING: Figure 1

Description

本発明は、有効成分として水素を含む、筋肉疲労等の予防・改善剤及び飲食品組成物、特に飲料に関する。   The present invention relates to a preventive / improving agent for muscle fatigue and the like, containing hydrogen as an active ingredient, and a food / beverage composition, particularly a beverage.

運動後などに生じる筋肉疲労の解消手段としては、通常、自然回復を待つのが一般的である。症状が重い場合には、市販の抗炎症剤や鎮痛剤などを患部に塗布するか、筋肉疲労回復のために抗炎症性の医薬を経口摂取する等の処置が行われている。しかし、経口摂取されているものの多くは、ビタミン、ミネラルなど、広く疲労全般からの回復に有効とされた成分が配合されているに過ぎず、筋肉疲労に特化した成分を含むものではなかった。   As a means for relieving muscle fatigue that occurs after exercise or the like, it is common to wait for natural recovery. When the symptom is severe, treatments such as applying a commercially available anti-inflammatory agent or analgesic agent to the affected area, or orally taking an anti-inflammatory drug for recovery of muscle fatigue are performed. However, most of those taken orally contain only ingredients that are widely effective in recovering from general fatigue, such as vitamins and minerals, and did not contain ingredients specialized for muscle fatigue. .

健康志向の高まりを受け、サプリメントや健康食品の市場は尚も広がりを見せているが、中でも、抗疲労関連市場は伸長を続ける期待の市場である。従って、疲労、特に筋肉の疲労を気軽に且つ簡便に回復できる有効成分の探索が望まれている。   The market for supplements and health foods is still expanding due to the growing health consciousness, but the anti-fatigue market is one that is expected to continue to grow. Accordingly, it is desired to search for an effective ingredient that can easily and easily recover fatigue, particularly muscle fatigue.

近年市場を賑わせている飲料として、水素を高濃度で水に溶解した「水素水」がある。水素は無味、無臭、無色で体に無害な気体であり、抗酸化作用などの種々の健康増進作用が知られている。機能性を付与する観点から、水素水に更に機能性原料を配合した水素含有飲料(特許文献1)や、また風味を改善する観点から、水素を添加した乳含有飲料(特許文献2)等も知られているが、水素自体が特定の疲労に直接的に作用するといった知見については現在まで知られていなかった。   As a beverage that has become popular in recent years, there is “hydrogen water” in which hydrogen is dissolved in water at a high concentration. Hydrogen is a gas that is tasteless, odorless, colorless and harmless to the body, and various health promoting actions such as an antioxidant action are known. From the viewpoint of imparting functionality, a hydrogen-containing beverage in which a functional raw material is further blended with hydrogen water (Patent Document 1), and a milk-containing beverage to which hydrogen has been added (Patent Document 2) from the viewpoint of improving flavor. Although known, the knowledge that hydrogen itself directly acts on specific fatigue has not been known so far.

特開2013−169153号報JP 2013-169153 A 特開2016−123358号公報JP 2006-123358 A

本発明は、新規な筋肉疲労等の予防・改善剤及び飲食品組成物を提供することを目的とする。   An object of the present invention is to provide a novel preventive / ameliorating agent such as muscle fatigue and a food or beverage composition.

本発明者らは、驚くべきことに、水素に筋肉疲労や肩こりを回復させる効果があることを見出し、本発明を完成させるに至った。   The present inventors have surprisingly found that hydrogen has an effect of restoring muscle fatigue and stiff shoulders, and completed the present invention.

即ち、本願は以下の発明を包含する。
[1]水素を有効成分として含む、筋肉疲労の予防・改善剤。
[2]水素の含有量が0.06mg〜1.60mgである、[1]に記載の筋肉疲労の予防・改善剤。
[3]水素の濃度が0.3〜1.6ppmである、[1]又は[2]に記載の筋肉疲労予防・改善剤。
[4]疲労の程度がVisual Analogue Scale(VAS)検査によって決定される、[1]〜[3]のいずれかに記載の筋肉疲労の予防・改善剤。
[5]被験者に一日1回以上、一週間以上投与される、[1]〜[4]のいずれかに記載の筋肉疲労の予防・改善剤。
[6][1]〜[5]のいずれかに記載の筋肉疲労の予防・改善剤を含む、筋肉疲労予防・改善のための飲食品組成物。
[7]飲料の形態である、[6]に記載の組成物。
[8]水素を有効成分として含む、肩こりの予防・改善剤。
[9]水素の含有量が0.06mg〜1.60mgである、[8]に記載の肩こりの予防・改善剤。
[10]水素の濃度が0.3〜1.6ppmである、[8]又は[9]に記載の肩こりの予防・改善剤。
[11]肩こりの程度がVAS検査によって決定される、[8]〜[10]のいずれかに記載の肩こりの予防・改善剤。
[12]被験者に一日1回以上、一週間以上投与される、[8]〜[11]のいずれかに記載の肩こりの予防・改善剤。
[13][8]〜[12]のいずれかに記載の肩こりの予防・改善剤を含む、肩こりの予防・改善のための飲食品組成物。
[14]飲料の形態である、[13]に記載の組成物。
That is, this application includes the following inventions.
[1] A preventive / ameliorating agent for muscle fatigue containing hydrogen as an active ingredient.
[2] The preventive / improving agent for muscle fatigue according to [1], wherein the hydrogen content is 0.06 mg to 1.60 mg.
[3] The muscle fatigue prevention / amelioration agent according to [1] or [2], wherein the hydrogen concentration is 0.3 to 1.6 ppm.
[4] The preventive / ameliorating agent for muscle fatigue according to any one of [1] to [3], wherein the degree of fatigue is determined by Visual Analogue Scale (VAS) test.
[5] The muscular fatigue prevention / amelioration agent according to any one of [1] to [4], which is administered to a subject once or more times a day for one week or more.
[6] A food and drink composition for preventing and improving muscle fatigue, comprising the agent for preventing and improving muscle fatigue according to any one of [1] to [5].
[7] The composition according to [6], which is in the form of a beverage.
[8] A stiff shoulder prevention / amelioration agent comprising hydrogen as an active ingredient.
[9] The stiff shoulder prevention / improving agent according to [8], wherein the hydrogen content is 0.06 mg to 1.60 mg.
[10] The stiff shoulder prevention / improving agent according to [8] or [9], wherein the hydrogen concentration is 0.3 to 1.6 ppm.
[11] The stiff shoulder prevention / improving agent according to any one of [8] to [10], wherein the degree of shoulder stiffness is determined by a VAS test.
[12] The stiff shoulder prevention / amelioration agent according to any one of [8] to [11], which is administered to a subject once or more times a day for one week or more.
[13] A food and beverage composition for preventing and improving shoulder stiffness, comprising the shoulder stiffness preventing and improving agent according to any one of [8] to [12].
[14] The composition according to [13], which is in the form of a beverage.

無味、無臭、無色で体に無害な気体である水素を有効成分とすることにより、従来、抗炎症剤の摂取に抵抗があった消費者でも気軽で簡便に筋肉痛や肩こりを予防・回復することが可能になる。   By using hydrogen, which is a tasteless, odorless, colorless and harmless gas as an active ingredient, even consumers who have been resistant to taking anti-inflammatory agents can easily prevent and recover muscle pain and stiff shoulders. It becomes possible.

図1は、イオン交換水に水素を約1.32ppm含有させた水(飲料2)による筋肉痛軽減効果をVAS検査により評価したグラフである。筋肉痛評価は運動前を0.0(無い)として、運動直後と休憩後に評価した。結果は被験者10名の平均である。なお、コントロールとしてイオン交換水を用いた(飲料1)。FIG. 1 is a graph in which the muscle pain alleviation effect of water (beverage 2) containing about 1.32 ppm of hydrogen in ion-exchanged water is evaluated by a VAS test. Myalgia was evaluated as 0.0 (no) before exercise, immediately after exercise and after break. The result is the average of 10 subjects. In addition, ion-exchange water was used as a control (beverage 1). 図2は、イオン交換水に水素を約1.35ppm含有させた水(飲料2)による肩凝り軽減効果をVAS検査により評価したグラフである。肩凝りの評価は肩こりが全く無い状態を0.0(無い)として、起床時と就寝前に評価した。結果は被験者10名の平均である。なお、コントロールとしてイオン交換水を用いた(飲料1)。FIG. 2 is a graph in which shoulder stiffness mitigating effect of water (beverage 2) containing about 1.35 ppm of hydrogen in ion-exchanged water is evaluated by VAS inspection. The evaluation of stiff shoulders was evaluated at the time of getting up and before going to bed, assuming that there was no stiff shoulder at all (0.0). The result is the average of 10 subjects. In addition, ion-exchange water was used as a control (beverage 1).

(予防・改善剤)
本発明に係る予防・改善剤は、有効成分として水素を含む。本明細書で使用する場合、「疲労」とは、主に肉体的活動により生じた独特の不快感と休養を求める欲求を伴う身体機能の減弱状態、例えば筋肉の疲労又は損傷、特に筋肉痛をいう。好ましくは、筋肉疲労は運動直後の疲労感に起因するものではない。また、「肩こり」とは、首すじ、首のつけ根から、肩又は背中にかけて知覚される不快感、例えば張った、凝った、痛いなどの感じを意味し、頭痛や吐き気を伴うこともある。
(Prevention / improvement agent)
The preventive / ameliorating agent according to the present invention contains hydrogen as an active ingredient. As used herein, “fatigue” refers to a condition of diminished physical function accompanied by unique discomfort and a desire for rest, mainly caused by physical activity, such as muscle fatigue or damage, particularly muscle pain. Say. Preferably, muscle fatigue is not due to a feeling of fatigue immediately after exercise. “Stiff shoulder” means a feeling of discomfort perceived from the neck line or base of the neck to the shoulder or back, for example, tension, stiffness, pain, etc., and may be accompanied by a headache or nausea.

また、本明細書で使用する場合、「予防・改善」とは、疲労や肩こり、例えば筋肉の疲労又は損傷を防ぐか、あるいはそれらの症状を疲労等の不快感を感じる前の状態にまで回復させること、特に筋肉痛の改善の場合、痛みを緩和させ、パフォーマンスを疲労前の状態まで実質的に回復させることを意味する。疲労や痛み、あるいはそれらからの予防や改善は主観的な感覚ではあるが、可能な限り客観的に評価することが好ましい。例えば、Visual Analogue Scale(VAS)法などの主観的な感覚を数値化して評価する方法によれば、疲労等の症状とその回復の程度をパラメーターとして評価することが可能になる。より具体的には、VASに基づき筋肉の疲労度を評価する場合、0〜100mmのスケールにおいて(通常、長さ100mmの線の上で)、運動前の筋肉の痛み(つまり、痛みがない状態)を「0」mm、過去に経験した最も強い痛みを「100」mmとし、特定の時点(運動前、運動直後、休憩後)で被験者自らが感じる痛みが0(ない)〜100(痛い)の範囲内で評点される。痛みの改善もVAS法で評価することができ、例えば、運動後に感じた痛みの数値が有意に減少した場合に筋肉痛や肩こりが改善したと評価してもよい。   In addition, as used herein, “prevention / improvement” refers to preventing fatigue and stiff shoulders, such as muscle fatigue or damage, or restoring those symptoms to a state prior to feeling discomfort such as fatigue. In particular, in the case of amelioration of muscle pain, it means that the pain is alleviated and the performance is substantially restored to the pre-fatigue state. Although fatigue and pain, or prevention and improvement from them are subjective sensations, it is preferable to evaluate them as objectively as possible. For example, according to a method for quantifying and evaluating a subjective feeling such as the Visual Analogue Scale (VAS) method, it is possible to evaluate symptoms such as fatigue and the degree of recovery thereof as parameters. More specifically, when assessing muscle fatigue based on VAS, muscle pain before exercise (ie, no pain) on a 0-100 mm scale (usually on a 100 mm long line) ) Is “0” mm, the strongest pain experienced in the past is “100” mm, and the pain felt by the subject himself at a specific time point (before exercise, immediately after exercise, after break) is 0 (no) to 100 (pain) Scored within the range of The improvement of pain can also be evaluated by the VAS method. For example, when the value of pain felt after exercise is significantly reduced, it may be evaluated that muscle pain or shoulder stiffness has improved.

本発明をコントロールとの比較で評価する場合、評点(通常は平均値)の差異が有意な差異であるか否かについて、有意確率(p)を算出することにより評価することができる。なお有意確率pの算出は、統計学上で既知の方法、例えばSPSS14.0を使用したt検定により行ってもよい。一般的に有意差はp<0.05(5%)であるとされるが、有意差を示唆する数値としてp≦0.1を基準として評価を行うこともできる。   When the present invention is evaluated by comparison with a control, it can be evaluated by calculating a significance probability (p) as to whether or not the difference in the score (usually the average value) is a significant difference. The significance probability p may be calculated by a statistically known method, for example, a t-test using SPSS 14.0. Generally, the significant difference is assumed to be p <0.05 (5%), but evaluation can be performed on the basis of p ≦ 0.1 as a numerical value suggesting the significant difference.

予防・改善剤に水素を含有させる方法は特に限定されないが、例えば、標準大気圧以上の水素ガス若しくは水素ガスを含有する気体を細かい気泡の状態で溶媒中に吹き込む方法(所謂バブリング)、または、気体透過膜を介して、液体溶媒中に水素を注入する方法等が挙げられる。これら以外の方法であっても、水素を所定の濃度以上に含有させることが可能な方法であれば溶解方法は問わない。   The method for containing hydrogen in the preventive / improving agent is not particularly limited. For example, a method in which hydrogen gas having a standard atmospheric pressure or higher or a gas containing hydrogen gas is blown into a solvent in a state of fine bubbles (so-called bubbling), or Examples thereof include a method of injecting hydrogen into a liquid solvent through a gas permeable membrane. Even if it is a method other than these, as long as it is a method which can be made to contain hydrogen more than predetermined concentration, the dissolution method will not ask | require.

水素を含有させる溶媒は水が好ましいが、本発明の効果が奏され、尚且つ飲料に適したものであれば特に限定されない。水は、飲用に適しているものであれば、硬水、軟水の種類やその他の性質は問われない。   The solvent containing hydrogen is preferably water, but is not particularly limited as long as the effect of the present invention is achieved and it is suitable for beverages. As long as water is suitable for drinking, the kind of hard water and soft water and other properties are not limited.

水素は、溶媒に含有されてから最終製品としての予防・改善剤が使用されるまでの間、最終製品としての予防・改善剤において溶解した状態で存在していることが好ましい。予防・改善剤における水素の濃度は0.3ppm以上が好ましい。一日あたりの水素の摂取量は症状に応じて変動し得るが、例えば、0.3ppmの濃度の水素水200mlを一日一本以上摂取するのが好ましい(すなわち0.06mg以上)。摂取量の上限は、例えば、1.60mg程度であると想定される(1.6ppm(飽和濃度)×1000ml)。一日あたりの水素の摂取量は好ましくは0.16〜1.20mg、より好ましくは0.24〜1.20mgである。   It is preferable that hydrogen is present in a dissolved state in the preventive / improving agent as the final product from when it is contained in the solvent until the preventive / improving agent as the final product is used. The concentration of hydrogen in the preventive / ameliorating agent is preferably 0.3 ppm or more. Although the intake amount of hydrogen per day may vary depending on the symptoms, for example, it is preferable to take 200 ml of hydrogen water having a concentration of 0.3 ppm at least once a day (that is, 0.06 mg or more). The upper limit of intake is assumed to be, for example, about 1.60 mg (1.6 ppm (saturated concentration) × 1000 ml). The intake amount of hydrogen per day is preferably 0.16 to 1.20 mg, more preferably 0.24 to 1.20 mg.

予防・改善剤は水素を高濃度で含有している水素水、つまり高濃度水素水そのものであってもよい。高濃度水素水は、溶媒である水に、1〜数ppmといった水素の飽和溶解量と比較して高い濃度に水素を溶解または視認できない程度の微細気泡の状態で含有させた水をいう。   The preventive / improving agent may be hydrogen water containing hydrogen at a high concentration, that is, high-concentration hydrogen water itself. High-concentration hydrogen water refers to water that is contained in the state of fine bubbles in such a degree that hydrogen cannot be dissolved or visually recognized at a high concentration compared to the saturated dissolution amount of hydrogen such as 1 to several ppm in water as a solvent.

本発明において水素水は、水素分子を溶解又は分散させたもの指す。なお、大気中においても微量の水素は存在しており、大気圧下でも当該微量水素は水に溶けるが、本願においては特に別途水素を添加していないイオン交換水、蒸留水等は水素水に含まれないものとした。水素を含有させる方法としては、例えば、特許5746411号に開示した方法を採用してもよいが、その他公知の方法を選択してもよい。なお、出願人が販売する水素水の水素濃度は、工場出荷時から賞味期限までの間、未開封の場合0.3ppm以上を維持している。   In the present invention, hydrogen water refers to a solution in which hydrogen molecules are dissolved or dispersed. A trace amount of hydrogen exists even in the atmosphere, and the trace amount of hydrogen is soluble in water even under atmospheric pressure. However, in the present application, ion-exchanged water, distilled water, etc., to which hydrogen is not separately added, are in the hydrogen water. Not included. As a method for containing hydrogen, for example, the method disclosed in Japanese Patent No. 5746411 may be adopted, but other known methods may be selected. In addition, the hydrogen concentration of the hydrogen water sold by the applicant is maintained at 0.3 ppm or more when unopened from the time of shipment from the factory to the expiration date.

予防・改善剤の投与回数又はその頻度は、疲労の症状に応じて適宜判断される。例えば、カルボーネン法の計算式にもとづき、運動強度が60%程度となるよう目標心拍数を設定し50分程度運動した場合、被験者に対して運動後に一日1回以上、好ましくは3回以上、一週間以上投与することが想定される。投与のタイミングは、肉体疲労をもたらす活動の後又はその最中のみならず、疲労等の症候を予防する観点から活動前であってもよい。例えば、筋肉疲労を発生し得る運動の前に、被験者は予め筋肉疲労予防・改善剤を摂取することもできる。   The frequency or frequency of administration of the preventive / ameliorating agent is appropriately determined according to the symptoms of fatigue. For example, when the target heart rate is set so that the exercise intensity is about 60% based on the calculation formula of the carbonnen method and exercised for about 50 minutes, the subject is exercised once or more after exercise, preferably 3 times or more, It is envisaged to administer for a week or more. The timing of administration may be not only after or during the activity that causes physical fatigue, but also before the activity from the viewpoint of preventing symptoms such as fatigue. For example, the subject can take a muscle fatigue preventive / ameliorating agent in advance before exercise that may cause muscle fatigue.

予防・改善剤の形態は、水素を含有させることができるかぎり特に制限はないが、水素を保持する観点から液体の形態であることが好ましい。予防・改善剤には水素以外にも、筋肉疲労等の症候の予防・改善効果を奏することが知られている成分を有効成分として含めることができる。有効成分以外にも、健康食品、健康補助食品等の食品組成物又は飲料組成物、更には医薬に含まれる任意の成分を含めてもよい。   The form of the preventive / ameliorating agent is not particularly limited as long as it can contain hydrogen, but is preferably a liquid form from the viewpoint of retaining hydrogen. In addition to hydrogen, the preventive / ameliorating agent can contain, as an active ingredient, a component known to exert a preventive / ameliorating effect on symptoms such as muscle fatigue. In addition to the active ingredients, food compositions such as health foods and health supplements or beverage compositions, and any ingredients contained in medicines may also be included.

(飲食品組成物)
本発明に係る筋肉疲労や肩こりの予防・改善のための飲食品組成物は、有効成分として上予防・改善剤を含む。組成物中の水素は予防・改善効果を奏する限り特に限定されないが、その有効量は予防・改善剤と実質的に同じである。
(Food and beverage composition)
The food / beverage product composition for preventing / improving muscle fatigue and stiff shoulders according to the present invention contains a top preventive / improving agent as an active ingredient. Hydrogen in the composition is not particularly limited as long as it has a preventive / ameliorating effect, but its effective amount is substantially the same as the preventive / ameliorating agent.

本明細書で使用する場合、「組成物」とは混ぜ物を意味するものであって、その形態は主に液体状であることが想定される。固体として存在することを排除するものではないが、水素の物理的な性質を考慮すると、本発明に係る組成物は固体よりも液体であることが好ましい。   As used herein, “composition” means a mixture and its form is assumed to be predominantly liquid. Although it does not exclude being present as a solid, in view of the physical properties of hydrogen, the composition according to the present invention is preferably a liquid rather than a solid.

用途面から見た場合、組成物は、医薬組成物;医薬部外品組成物;薬理効果を備えたいわゆる健康食品、健康補助食品、栄養機能食品、特定保健用食品、機能性食品等の食品組成物;飲料や食品に添加するための配合用組成物(食品添加物);該配合用組成物を添加して飲料とした飲料組成物等に区分することができる。   From the viewpoint of use, the composition is a pharmaceutical composition; a quasi-drug composition; a so-called health food, health supplement, nutritional functional food, food for specified health use, functional food, etc. having a pharmacological effect. Composition: Composition for blending to be added to beverages and foods (food additive); Beverage composition and the like which are prepared by adding the composition for blending can be classified.

本発明の組成物を、疲労に関連性のある疾病・障害を予防・治療するための医薬用途に用いる場合には、常法に従って薬学的に許容される担体とともに種々の剤型の医薬組成物とすることができる。   When the composition of the present invention is used for a pharmaceutical use for preventing or treating a disease or disorder associated with fatigue, the pharmaceutical composition of various dosage forms together with a pharmaceutically acceptable carrier according to a conventional method. It can be.

組成物が液体の製剤である場合は、本発明の組成物に矯味剤、緩衝剤、安定化剤、矯臭剤等を加えて常法により内服液剤、シロップ剤、エリキシル剤等を製造することができる。この場合矯味剤としては上記に挙げられたもので良く、緩衝剤としてはクエン酸ナトリウム等が、安定化剤としてはトラガント、アラビアゴム、ゼラチン等が挙げられる。   When the composition is a liquid preparation, an oral solution, syrup, elixir or the like can be produced by a conventional method by adding a flavoring agent, buffer, stabilizer, flavoring agent, etc. to the composition of the present invention. it can. In this case, the flavoring agents may be those listed above, examples of the buffer include sodium citrate, and examples of the stabilizer include tragacanth, gum arabic, and gelatin.

また、本発明の組成物は、健康食品、健康補助食品等の食品組成物あるいは飲料組成物として用いることも可能である。ここで好ましい食品組成物、飲料組成物としては、栄養ドリンク、スポーツドリンク、果実飲料、野菜飲料、炭酸飲料、茶飲料、コーヒー飲料、スープ飲料等が例示することができ、特に種々の生理効果を有し、健康に寄与する飲料として、スポーツドリンクやエナジードリンクとするならば、呈味がよく、抗疲労効果も期待されるため好ましい。   The composition of the present invention can also be used as a food composition such as health foods and health supplements, or a beverage composition. Examples of preferred food compositions and beverage compositions here include nutritional drinks, sports drinks, fruit drinks, vegetable drinks, carbonated drinks, tea drinks, coffee drinks, soup drinks, and various physiological effects. It is preferable to use a sports drink or an energy drink as a beverage that has health and contributes to health because it has a good taste and an anti-fatigue effect.

本発明の実施態様が、スポーツドリンク、エナジードリンクなどの飲料(液状)である場合には、500mLまたは500g入り容器、好ましくは350mLまたは350g入り容器、さらに好ましくは200mL容器または200g入り容器に1回当たりの摂取量を添加すると、短時間で効率的な摂取が可能となる。   When the embodiment of the present invention is a beverage (liquid) such as a sports drink or an energy drink, it is once in a 500 mL or 500 g container, preferably a 350 mL or 350 g container, more preferably a 200 mL container or a 200 g container. When the per capita intake is added, efficient intake is possible in a short time.

これら飲食品組成物の製造方法は常法に従えばよく、適切なタイミングで水素を含有させることにより調製すればよい。また、飲食品組成物の製造に際しては、その他の食品素材、すなわち各種糖質や乳化剤、増粘剤、甘味料、酸味料、香料、アミノ酸、果汁等を適宜添加することができる。具体的には、蔗糖、異性化糖、グルコース、フラクトース、パラチノース、トレハロース、ラクトース、キシロース等の糖類、ソルビトール、キシリトール、エリスリトール、ラクチトール、パラチニット、還元水飴、還元麦芽糖水飴等の糖アルコール類、アスパルテーム、ステビア、アセスルファムカリウム、スクラロース等の高甘味度甘味料、蔗糖脂肪酸エステル、グリセリン脂肪酸エステル、レシチン等の乳化剤、カラギーナン、キサンタンガム、グァーガム、ペクチン、ローカストビーンガム等の増粘(安定)剤、クエン酸、乳酸、リンゴ酸等の酸味料、レモン果汁、オレンジ果汁、ベリー系果汁等の果汁類等が挙げられる。この他にも、ビタミンA、ビタミンB類、ビタミンC、ビタミンD、ビタミンE等のビタミン類やカルシウム、鉄、マンガン、亜鉛等のミネラル類等を添加することが可能である。   The manufacturing method of these food-drinks compositions should just follow a conventional method, and should just prepare it by making hydrogen contain at an appropriate timing. In the production of the food / beverage product composition, other food materials, that is, various sugars, emulsifiers, thickeners, sweeteners, acidulants, fragrances, amino acids, fruit juices and the like can be appropriately added. Specifically, sugars such as sucrose, isomerized sugar, glucose, fructose, palatinose, trehalose, lactose, xylose, sugar alcohols such as sorbitol, xylitol, erythritol, lactitol, palatinit, reduced starch syrup, reduced maltose starch syrup, aspartame, High-intensity sweeteners such as stevia, acesulfame potassium, sucralose, emulsifiers such as sucrose fatty acid ester, glycerin fatty acid ester, lecithin, thickening (stabilizing) agents such as carrageenan, xanthan gum, guar gum, pectin, locust bean gum, citric acid, Examples include acidulants such as lactic acid and malic acid, and fruit juices such as lemon juice, orange juice, and berry juice. In addition, vitamins such as vitamin A, vitamin B, vitamin C, vitamin D, and vitamin E, and minerals such as calcium, iron, manganese, and zinc can be added.

(容器)
本発明に係る予防・改善剤及び飲食品組成物は、容器に充填されて提供される。かかる容器としては、缶(アルミニウム、スチール)、レトルトパウチ、瓶(ガラス)、PETボトル、紙容器等が挙げられる。ここで、飲料としての水素水においては、水素のバリア性が要求されるため、金属缶、金属積層フィルムを用いた所謂パウチ形態の容器、ガラス瓶を用いることが好ましい。
(container)
The preventive / ameliorating agent and food / beverage product composition according to the present invention are provided by being filled in a container. Examples of such containers include cans (aluminum, steel), retort pouches, bottles (glass), PET bottles, paper containers, and the like. Here, since hydrogen water as a beverage is required to have a hydrogen barrier property, it is preferable to use a metal can, a so-called pouch-shaped container using a metal laminated film, or a glass bottle.

以下、具体例を挙げて、本発明をさらに具体的に説明する。なお、本発明は、これにより限定されるものではない。   Hereinafter, the present invention will be described more specifically with reference to specific examples. In addition, this invention is not limited by this.

(実施例1:水素含有飲料による運動後の筋肉疲労軽減作用)
水素含有飲料の摂取による筋肉疲労軽減作用を検討した。疲労負荷にはエルゴメーター(エアロバイクai、コンビ株式会社)を用い、筋肉疲労の軽減作用の評価には自己評価尺度であるVisual Analog Scale(VAS)を用いた。
(Example 1: Effect of reducing muscle fatigue after exercise by a hydrogen-containing beverage)
We investigated the effect of reducing muscle fatigue by ingesting a hydrogen-containing beverage. An ergometer (Aerobike ai, Combi Co., Ltd.) was used for the fatigue load, and Visual Analog Scale (VAS), which is a self-assessment scale, was used for evaluating the effect of reducing muscle fatigue.

(被験者)
無作為に選択された健常な成人男性5名(36.2±7.6歳)、成人女性5名(33.2±14歳)を被験者とし、これら全員に飲料1(プラセボ飲料:イオン交換水)を摂取する試験と飲料2(イオン交換水に水素ガスを給気し水素を含有させた水(水素水))を摂取する試験の合計2回の試験を実施した(クロスオーバー試験)。水素水(1本300ml)における溶存水素濃度は約1.32ppm(0.396mg/回)であり、被験者は300mlの飲料2を1日3本、自由なタイミングで摂取した(水素摂取量:1.188mg/日)。飲料2における水素濃度の調節は、特許第5746411号に記載の方法に従い、中空糸モジュールを用いて脱気水に水素を吹き込むことで行った。溶存水素濃度は、ユニセンス社溶存水素計を用いて測定した(検出限界:0.005ppm)飲料はいずれも飲み口付きアルミパウチに密封充填されており、飲用時に開栓し、飲み口から直接摂取した。
(subject)
Five healthy adult males (36.2 ± 7.6 years old) and 5 adult females (33.2 ± 14 years old), who were selected at random, were the subjects, and all of them were drink 1 (placebo drink: ion exchange) A total of two tests were conducted (a crossover test): a test for ingesting water) and a test for drinking 2 (water in which hydrogen gas was supplied to ion-exchanged water to contain hydrogen (hydrogen water)). The dissolved hydrogen concentration in hydrogen water (one 300 ml) was about 1.32 ppm (0.396 mg / dose), and the subject took 300 ml of beverage 2 three times a day at any time (hydrogen intake: 1 .188 mg / day). The hydrogen concentration in the beverage 2 was adjusted by blowing hydrogen into deaerated water using a hollow fiber module according to the method described in Japanese Patent No. 5746411. Dissolved hydrogen concentration was measured using a Unisense dissolved hydrogen meter (detection limit: 0.005 ppm). All beverages were hermetically sealed in an aluminum pouch with a drinking mouth, opened at the time of drinking, and taken directly from the drinking mouth. did.

エアロバイクの運動強度は60%に設定した。この条件は有酸素運動と無酸素運動の境界域であるAT(Anaerobic Threshold :嫌気性代謝閾値)付近の運動を想定したものである。よって、軽度の運動のみならず日常生活の労作も評価の対象とした条件である。なお、試験はカルボーネン法により運動強度60%となるよう目標心拍数を設定し心拍数一定条件で実施した。より具体的には、目標心拍数={(220−年齢)−安静時心拍数}×運動強度(0.6)+安静時心拍数の計算式において運動強度が60%となる目標心拍数を設定した。   The exercise intensity of the exercise bike was set at 60%. This condition assumes exercise in the vicinity of AT (Anaerobic Threshold), which is the boundary between aerobic and anaerobic exercise. Therefore, not only mild exercise but also daily life effort is a condition for evaluation. The test was carried out under the constant heart rate condition by setting the target heart rate so that the exercise intensity was 60% by the carbonnen method. More specifically, target heart rate = {(220−age) −resting heart rate} × exercise intensity (0.6) + target heart rate at which the exercise intensity is 60% in the calculation formula of resting heart rate. Set.

疲労軽減作用の確認試験は次のようなスケジュールで実施した。
(1)摂取前の運動負荷試験
(1−1)運動前の筋肉の疲労度調査(VAS)
(1−2)強度60%の運動を50分間実施
(1−3)運動直後の筋肉の疲労度調査(VAS)
(1−4)試験飲料を300ml摂取したのち30分休憩
(1−5)休憩後の筋肉の疲労度調査(VAS)
(2)試験飲料(プラセボ又は水素水)を1週間摂取(300ml/1回、試験飲料を1日3回自由摂取した。各回の摂取タイミングは起床〜就寝まで任意の間で被験者の任意とした。)。なお、被験者の半分はプラセボ、残り半分は水素水を摂取し、(4)の工程でプラセボと水素水を入れ替えて、(1)〜(3)と同様の試験を行った。
(3)摂取期間後の運動負荷試験
(3−1)運動前の筋肉の疲労度調査(VAS)
(3−2)強度60%の運動を50分間実施
(3−3)運動直後の筋肉の疲労度調査(VAS)
(3−4)試験飲料を300ml摂取したのち30分休憩
(3−5)休憩後の筋肉の疲労度調査(VAS)
(4)プラセボと水素水の摂取被験者を入れ替え、(1)〜(3)の試験を実施(クロスオーバー試験)。なお、被験者を入れ替える際には、インターバル期間(1週間)を設け、その後(1)の摂取期間前の検証を実施した。
The confirmation test of the fatigue reduction action was carried out according to the following schedule.
(1) Exercise load test before ingestion (1-1) Investigation of muscle fatigue before exercise (VAS)
(1-2) Exercise with 60% intensity for 50 minutes (1-3) Muscle fatigue survey immediately after exercise (VAS)
(1-4) 30 minutes break after ingesting 300 ml of test beverage (1-5) Muscle fatigue survey after break (VAS)
(2) Ingestion of test beverage (placebo or hydrogen water) for one week (300 ml / time, test beverage was freely ingested three times a day. The timing of each ingestion was arbitrary between subjects from waking up to bedtime. .) Half of the subjects took placebo and the other half took hydrogen water, and the same test as in (1) to (3) was performed by replacing placebo and hydrogen water in the step (4).
(3) Exercise load test after intake period (3-1) Investigation of muscle fatigue before exercise (VAS)
(3-2) Exercise with 60% strength for 50 minutes (3-3) Investigation of muscle fatigue immediately after exercise (VAS)
(3-4) 30 minutes break after ingesting 300 ml of test beverage (3-5) Muscle fatigue survey after break (VAS)
(4) The placebo and hydrogen water intake subjects were exchanged, and the tests (1) to (3) were conducted (crossover test). In addition, when changing a test subject, the interval period (1 week) was provided, and verification before the intake period of (1) was implemented after that.

なお、最初にプラセボ又は水素水を摂取する前の1週間、及び摂取対象飲料の入れ替え時の1週間のインターバル期間は夫々以下に示す摂取前の運動負荷試験期間に該当する。   In addition, the interval period of one week before taking placebo or hydrogen water for the first time and one week at the time of replacement | exchange of a drink for ingestion corresponds to the exercise test period before ingestion shown below, respectively.

本実施例におけるVAS検査は、被験者が、特定の時点(運動前、運動直後、休憩後)で「筋肉痛はありますか?」という問いに対して運動前の状態を0.0(ない)として、0.0cm(ない)〜10.0cm(痛い)の線分上を自身の状態を記入することで行った。10.0は、筋肉痛以外の痛みを含めて過去に被験者自身が感じたことのある最大の痛みを指す。なお、被験者が記入した線分上の位置を定規により測定し、小数点第一まで計測した数値を採用した。   In the VAS test in this example, the subject was given a pre-exercise state of 0.0 (no) in response to the question “Is there muscle pain?” At a specific time point (before exercise, immediately after exercise, after break). It was performed by writing its own state on a line segment of 0.0 cm (not) to 10.0 cm (pain). 10.0 indicates the maximum pain that the subject himself has felt in the past, including pain other than muscle pain. In addition, the position on the line segment entered by the subject was measured with a ruler, and a numerical value measured to the first decimal point was adopted.

(評価方法)
プラセボを摂取した場合と水素水を摂取した場合のそれぞれについて、運動後30分経過した後(休憩後)のVAS法評価結果の数値を全被験者分合計し、その合計値を被験者数で割ることにより平均値を算出した。プラセボ及び水素水における上記平均値の差異が有意な差異であるか否かについて、有意確率(p)を算出することにより評価した。なお、有意確率pは、SPSS14.0を使用しt検定を行うことで算出した。本実施例においては、有意差を示唆する数値としてp≦0.1を基準として評価を行った。
(Evaluation method)
For each of the placebo intake and hydrogen water intake, sum the numerical values of the VAS method evaluation results after 30 minutes after exercise (after a break) for all subjects and divide the total value by the number of subjects. The average value was calculated by It was evaluated by calculating the significance probability (p) whether the difference of the said average value in a placebo and hydrogen water is a significant difference. The significance probability p was calculated by performing t-test using SPSS 14.0. In this example, evaluation was performed based on p ≦ 0.1 as a numerical value indicating a significant difference.

(結果・考察)
運動前のVAS評価を0.0とし、上記の条件で運動を行い、30分休憩した後に再度VAS評価をプラセボ及び水素水の両方で実施した。運動前と休憩後の疲労がプラセボと水素水でどのように変化するかを測定した結果、被験者10人の差異の平均は1.0であった(プラセボが0.8、水素水が−0.2)。測定値の標準偏差等のデータを加味し、有意確率を算出したところP=0.10となったため、有意差を示唆する結果が得られたと判断した。
(Results and discussion)
VAS evaluation before exercise was set to 0.0, exercise was performed under the above conditions, and after resting for 30 minutes, VAS evaluation was performed again with both placebo and hydrogen water. As a result of measuring how the fatigue before exercise and after break changed between placebo and hydrogen water, the average of the differences among 10 subjects was 1.0 (placebo was 0.8, hydrogen water was −0) .2). Taking into account data such as the standard deviation of the measured values and calculating the significance probability, it was P = 0.10, and it was judged that a result suggesting a significant difference was obtained.

詳細な要因は明確ではないが、蓄積疲労の回復過程において水素水が筋肉疲労の回復を補助する機能を有することが示唆された。   Although detailed factors are not clear, it was suggested that hydrogen water has a function to assist recovery of muscle fatigue in the recovery process of accumulated fatigue.

(実施例2:水素含有飲料による肩こりの軽減作用)
日常生活の労作で生じる肩こりの軽減作用について検討した。評価部位は肩とし、肩の筋肉の疲れ、すなわち肩こりについて実施例1と同様にVAS検査で評価した。
(Example 2: Relieving effect of stiff shoulders by a hydrogen-containing beverage)
We investigated the effect of reducing stiff shoulders that occur during daily life. The evaluation site was the shoulder, and the fatigue of the shoulder muscle, that is, the stiff shoulder, was evaluated by the VAS test in the same manner as in Example 1.

(被験者)
肩こりの状態とは無関係に無作為に選択された健常な日勤の男性15名(36.1±7.3歳)及び女性12名(38.3±7.2歳)を被験者とし、実施例1と同様のプラセボ(イオン交換水)及び水素水を用いてクロスオーバー試験を実施した。実施例1と同様の方法で、被験者毎にプラセボ及び水素水における評価差異を算出し、有意確率pの算出を行った。なお、実施例2においては、摂取期間は2週間とし、試験飲料の摂取量は1日1回200mlとした。水素水(1本200ml)における溶存水素濃度は約1.35ppm(0.270mg/回)であり、被験者は200mlの飲料2を1日1本摂取した(水素摂取量:0.270mg/日)。溶存水素濃度は、ユニセンス社溶存水素計を用いて測定した(検出限界:0.005ppm)。摂取タイミングは、実施例1と同様に起床〜就寝まで任意の間で被験者の任意とした。飲料はいずれも飲み口付きアルミパウチに密封充填されており、飲用時に開栓し、飲み口から直接摂取した。
(subject)
15 healthy day shift males (36.1 ± 7.3 years old) and 12 females (38.3 ± 7.2 years old) randomly selected regardless of their stiff shoulders A crossover test was performed using the same placebo (ion exchange water) and hydrogen water as in 1. In the same manner as in Example 1, the evaluation difference between placebo and hydrogen water was calculated for each subject, and the significance probability p was calculated. In Example 2, the intake period was 2 weeks, and the intake amount of the test beverage was 200 ml once a day. The dissolved hydrogen concentration in hydrogen water (200 ml per bottle) was about 1.35 ppm (0.270 mg / dose), and the subject took 200 ml of beverage 2 once a day (hydrogen intake: 0.270 mg / day). . The dissolved hydrogen concentration was measured using a Unisense dissolved hydrogen meter (detection limit: 0.005 ppm). The ingestion timing was arbitrarily determined by the subject between wake-up and bedtime in the same manner as in Example 1. All beverages were hermetically sealed in an aluminum pouch with a drinking mouth, opened at the time of drinking, and taken directly from the drinking mouth.

VAS検査は、実施例1と同様に被験者が、特定の時点(起床時及び就寝前)で「肩こりはありますか?」という問いに対して肩こりが全く無い状態を0.0(ない)として、0.0(ない)〜10.0(こっている)の線分上を自身の状態を記入することで行った。10.0は、過去に被験者自身が感じたことのある最悪の肩こりの状態を指す。なお、被験者が記入した線分上の位置を定規により測定し、小数点第一まで計測した数値を採用した。   In the VAS test, as in Example 1, when the subject has a stiff shoulder at the specific time (when waking up and before going to bed), the state where there is no stiff shoulder is 0.0 (not), It was performed by entering its own state on a line segment of 0.0 (not) to 10.0 (scratching). 10.0 indicates the worst state of stiff shoulder that the subject himself has felt in the past. In addition, the position on the line segment entered by the subject was measured with a ruler, and a numerical value measured to the first decimal point was adopted.

肩こり軽減作用の確認試験は次のようなスケジュールで実施した。
(1)摂取期間前の検証(1週間)
摂取開始前日の起床時及び就寝前に、肩こりの状態を被験者に確認し、VAS法に従い評点した。
(2)試験飲料の摂取と試験飲料摂取中の検証
(1)の検証の後、試験飲料の摂取を開始した。摂取期間は2週間とした。7日目、14日目の起床時及び就寝前に、(1)と同様に、肩こりの状態を被験者に確認し、VAS法に従い評点した。
(3)(1)〜(2)終了後のクロスオーバー試験
飲料を入れ替えて再度上記(1)から(4)までのサイクルを実施(クロスオーバー試験)した。なお、試験飲料を入れ替える際には、インターバル期間(1週間)を設け、当該インターバル期間に上記(1)の摂取期間前の検証を実施した。
The confirmation test for stiff shoulder reduction was carried out according to the following schedule.
(1) Verification before intake period (1 week)
Before waking up on the day before the start of intake and before going to bed, the subjects were checked for stiff shoulders and scored according to the VAS method.
(2) Intake of test beverage and verification during ingestion of test beverage After the verification in (1), ingestion of the test beverage was started. The intake period was 2 weeks. At the time of waking up on the 7th and 14th days and before going to bed, as in (1), the state of stiff shoulders was confirmed with the subject and scored according to the VAS method.
(3) Crossover test after completion of (1) to (2) The beverages were replaced and the cycle from (1) to (4) was performed again (crossover test). In addition, when replacing | exchanging a test drink, the interval period (1 week) was provided and the verification before the intake period of said (1) was implemented in the said interval period.

(評価方法)
(i)起床時と就寝前におけるVAS法評価結果の差異の算出
摂取前及び摂取後における、起床時と就寝前の肩こりの状態のVAS評価結果を比較し差異を算出した。
(ii)平均値の算出
同一日における(i)の結果を全被験者について合計した後、被験者数で割ることで当該日におけるVAS評価結果の差異の平均値を求めた。
(iii)有意差の判定
プラセボ、水素水それぞれにつき、摂取開始前後で、(ii)の結果を比較し、その差異が有意なものであるか否かについて、有意確率(p)を算出することにより評価した。
実施例1と同様、有意確率pは、SPSS14.0を使用しt検定を行うことで算出した。本実施例においては、有意差を示唆する数値としてp≦0.1を基準として評価を行った。
(Evaluation method)
(I) Calculation of difference between VAS method evaluation results at the time of getting up and before going to bed The difference was calculated by comparing the VAS evaluation results of the stiff shoulder state at the time of getting up and before going to bed before and after ingestion.
(Ii) Calculation of average value After totaling the results of (i) on the same day for all subjects, the average value of the difference in VAS evaluation results on that day was obtained by dividing by the number of subjects.
(Iii) Judgment of significant difference For each of the placebo and hydrogen water, compare the result of (ii) before and after ingestion and calculate the significance probability (p) as to whether or not the difference is significant. It was evaluated by.
Similar to Example 1, the significance probability p was calculated by performing a t-test using SPSS 14.0. In this example, evaluation was performed based on p ≦ 0.1 as a numerical value indicating a significant difference.

(結果・考察)
図2は、全被験者のVAS法での評価値の平均値を、摂取開始から同一の経過日数であるプラセボ及び水素水摂取におけるデータを比較した棒グラフである。試験飲料の摂取期間において、摂取開始から7日目まで有意差はない(p=0.14)ものの差が得られ始めており、14日目(p=0.02)において顕著な有意差が確認された。このことから、一日あたりの分子状水素摂取量が0.27mgとなるよう水素水を継続的に摂取した場合、日常生活における肩こりが軽減される傾向が示唆された。肩こりは、筋肉疲労による循環障害が要因であると考えられることから、実施例1と同様、就寝時や、日常のインターバル時間等に筋肉疲労が軽減されることで肩こりの軽減に繋がっているものと考えられる。
(Results and discussion)
FIG. 2 is a bar graph comparing the data of placebo and hydrogen water intake, which are the same number of elapsed days from the start of intake, with respect to the average value of evaluation values by the VAS method of all subjects. In the test beverage intake period, there is no significant difference from the start of intake to the 7th day (p = 0.14), but a significant difference is confirmed on the 14th day (p = 0.02). It was done. From this, it was suggested that when the hydrogen water was continuously ingested so that the molecular hydrogen intake per day was 0.27 mg, the shoulder stiffness in daily life was reduced. Since stiff shoulders are thought to be due to circulatory disturbance due to muscle fatigue, as in Example 1, muscle fatigue is reduced at bedtime and daily interval time, etc., leading to reduction in stiff shoulders it is conceivable that.

本発明によれば、従来型の抗炎症剤による筋肉痛や肩こりの治療に抵抗があった消費者でも気軽で簡便にこれらの症状を予防・改善することが可能になる。   According to the present invention, even consumers who are resistant to treatment of muscle pain and stiff shoulders with conventional anti-inflammatory agents can easily prevent and ameliorate these symptoms.

Claims (14)

水素を有効成分として含む、筋肉疲労の予防・改善剤。   An agent for preventing and improving muscle fatigue, containing hydrogen as an active ingredient. 水素の含有量が0.06mg〜1.60mgである、請求項1に記載の筋肉疲労の予防・改善剤。   The preventive / improving agent for muscle fatigue according to claim 1, wherein the hydrogen content is 0.06 mg to 1.60 mg. 水素の濃度が0.3〜1.6ppmである、請求項1又は2に記載の筋肉疲労予防・改善剤。   The agent for preventing or improving muscle fatigue according to claim 1 or 2, wherein the hydrogen concentration is 0.3 to 1.6 ppm. 疲労の程度がVisual Analogue Scale(VAS)検査によって決定される、請求項1〜3のいずれかに記載の筋肉疲労の予防・改善剤。   The preventive / improving agent for muscle fatigue according to any one of claims 1 to 3, wherein the degree of fatigue is determined by a Visual Analogue Scale (VAS) test. 被験者に一日1回以上、一週間以上投与される、請求項1〜4のいずれかに記載の筋肉疲労の予防・改善剤。   The agent for preventing / ameliorating muscle fatigue according to any one of claims 1 to 4, which is administered to a subject once or more times a day for one week or more. 請求項1〜5のいずれかに記載の筋肉疲労の予防・改善剤を含む、筋肉疲労予防・改善のための飲食品組成物。   A food and beverage composition for preventing and improving muscle fatigue, comprising the agent for preventing and improving muscle fatigue according to any one of claims 1 to 5. 飲料の形態である、請求項6に記載の組成物。   The composition of claim 6 in the form of a beverage. 水素を有効成分として含む、肩こりの予防・改善剤。   A stiff shoulder prevention / improving agent containing hydrogen as an active ingredient. 水素の含有量が0.06mg〜1.60mgである、請求項8に記載の肩こりの予防・改善剤。   The prophylactic / improving agent for stiff shoulders according to claim 8, wherein the content of hydrogen is 0.06 mg to 1.60 mg. 水素の濃度が0.3〜1.6ppmである、請求項8又は9に記載の肩こりの予防・改善剤。   The stiff shoulder prevention / improving agent according to claim 8 or 9, wherein the hydrogen concentration is 0.3 to 1.6 ppm. 肩こりの程度がVAS検査によって決定される、請求項8〜10のいずれかに記載の肩こりの予防・改善剤。   The prophylactic / ameliorating agent for stiff shoulders according to any one of claims 8 to 10, wherein the degree of stiff shoulders is determined by a VAS test. 被験者に一日1回以上、一週間以上投与される、請求項8〜11のいずれかに記載の肩こりの予防・改善剤。   The prophylactic / ameliorating agent for stiff shoulders according to any one of claims 8 to 11, which is administered to a subject once or more times a day for one week or more. 請求項8〜12のいずれかに記載の肩こりの予防・改善剤を含む、肩こりの予防・改善のための飲食品組成物。   A food / beverage product composition for prevention / improvement of stiff shoulders, comprising the preventive / improving agent for stiff shoulders according to claim 8. 飲料の形態である、請求項13に記載の組成物。   14. A composition according to claim 13 in the form of a beverage.
JP2017138035A 2017-07-14 2017-07-14 Preventive/ameliorating agent for muscular fatigue or the like, containing hydrogen, and food and drink composition Withdrawn JP2019017287A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2017138035A JP2019017287A (en) 2017-07-14 2017-07-14 Preventive/ameliorating agent for muscular fatigue or the like, containing hydrogen, and food and drink composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2017138035A JP2019017287A (en) 2017-07-14 2017-07-14 Preventive/ameliorating agent for muscular fatigue or the like, containing hydrogen, and food and drink composition

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021009385A Division JP7110418B2 (en) 2021-01-25 2021-01-25 Agent for preventing/improving muscle fatigue, etc. containing hydrogen, and food/beverage composition

Publications (1)

Publication Number Publication Date
JP2019017287A true JP2019017287A (en) 2019-02-07

Family

ID=65352466

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2017138035A Withdrawn JP2019017287A (en) 2017-07-14 2017-07-14 Preventive/ameliorating agent for muscular fatigue or the like, containing hydrogen, and food and drink composition

Country Status (1)

Country Link
JP (1) JP2019017287A (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016087523A (en) * 2014-10-31 2016-05-23 株式会社 伊藤園 Manufacturing method of gas dispersion liquid

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016087523A (en) * 2014-10-31 2016-05-23 株式会社 伊藤園 Manufacturing method of gas dispersion liquid

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
"水素水と肩こり", 水素水サーバー いい水アシスト, JPN6020013884, 27 June 2016 (2016-06-27), pages 1 - 4, ISSN: 0004491964 *
MEDICAL GAS RESEARCH, 2012年, vol. 2, JPN6020013882, pages 1 - 6, ISSN: 0004383992 *
近畿大医誌, 2010年, vol. 第35巻, 3,4号, JPN6021014934, pages 151 - 156, ISSN: 0004491965 *

Similar Documents

Publication Publication Date Title
JP6014083B2 (en) Sleepiness alarm composition
US20100316735A1 (en) Compositions and methods for reducing hangover symptoms
TWI664916B (en) The use of taste-improving agent for foods and drinks which have a fruity flavor
JP5574662B2 (en) Method for suppressing warming deterioration of fruit juice for warm sale, method for producing fruit juice for warm sale, and fruit juice drink for warm sale
JP2011120479A (en) Basic amino acid-containing packaged beverage
TWI304326B (en)
JP2017123841A (en) Jelly containing free amino acid or salt thereof
JP5721352B2 (en) Beverages containing vitamins
Singh et al. EFFICACY OF PRE EXERCISE CARBOHYDRATE DRINK (GATORADE) ON THE RECOVERY HEART RATE, BLOOD LACTATE AND GLUCOSE LEVELS IN SHORT TERM INTENSIVE EXERCISE.
JP2006193435A (en) Fatigue-improving agent
JP2003169642A (en) Beverage containing highly branched cyclic dextrin
JP4056905B2 (en) Vinegar drink
JP7110418B2 (en) Agent for preventing/improving muscle fatigue, etc. containing hydrogen, and food/beverage composition
JP2019017287A (en) Preventive/ameliorating agent for muscular fatigue or the like, containing hydrogen, and food and drink composition
Das et al. Toxic Level of Soft Drinks and Sports Drink on Health Status
US20180055850A1 (en) Synergistic nutraceutical beverage formulations providing enhanced thermogenesis, mental clarity, and stamina while minimizing adrenaline and dopamine concentration perturbations associated with withdrawal
JP2019170194A (en) Carbonated beverage
JP5688205B2 (en) An oral solution with reduced unpleasant taste and odor
JP2020028247A (en) Fatigue feeling-alleviating agent and food/drink composition for fatigue feeling-alleviation
KR102435548B1 (en) Liquid stick type energy sports drinks
CN110037221A (en) A kind of Dealcoholic solid beverage and preparation method thereof
JP6714984B2 (en) Container-packed acidic beverage with high citric acid content and reduced off-flavor derived from citric acid
US20230117995A1 (en) Consumable electrolyte compositions and methods of use thereof
US11344597B2 (en) Compositions for reducing or preventing development of symptoms of alcohol consumption
US20010055645A1 (en) Caffeinated fruit juices

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20190318

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20200512

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200625

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20201109

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210125

C60 Trial request (containing other claim documents, opposition documents)

Free format text: JAPANESE INTERMEDIATE CODE: C60

Effective date: 20210125

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20210318

C21 Notice of transfer of a case for reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C21

Effective date: 20210319

A912 Re-examination (zenchi) completed and case transferred to appeal board

Free format text: JAPANESE INTERMEDIATE CODE: A912

Effective date: 20210423

C211 Notice of termination of reconsideration by examiners before appeal proceedings

Free format text: JAPANESE INTERMEDIATE CODE: C211

Effective date: 20210427

C22 Notice of designation (change) of administrative judge

Free format text: JAPANESE INTERMEDIATE CODE: C22

Effective date: 20220614

C22 Notice of designation (change) of administrative judge

Free format text: JAPANESE INTERMEDIATE CODE: C22

Effective date: 20220802

C22 Notice of designation (change) of administrative judge

Free format text: JAPANESE INTERMEDIATE CODE: C22

Effective date: 20220819

C22 Notice of designation (change) of administrative judge

Free format text: JAPANESE INTERMEDIATE CODE: C22

Effective date: 20220822

C13 Notice of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: C13

Effective date: 20220907

A761 Written withdrawal of application

Free format text: JAPANESE INTERMEDIATE CODE: A761

Effective date: 20220914